How to use statins in patients with chronic liver disease

被引：33

作者：

Russo, MW ^{[1
]}

Jacobson, IM ^{[1
]}

机构：

[1] Weill Cornell Med Coll, Div Gastroenterol & Hepatol, Ctr Study Hepatitis C, New York, NY USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2004年 / 71卷 / 01期

关键词：

D O I：

10.3949/ccjm.71.1.58

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Clinicians may be concerned about prescribing statins to patients with chronic liver disease, but there is little evidence to suggest that drug-induced liver injury from statins is increased in these patients. Thus, we should prescribe statins for the same indications in patients with chronic liver disease as in patients without, but with closer monitoring. However, patients with acute liver disease (acute viral hepatitis, alcoholic hepatitis) should not take statins until they have recovered.

引用

页码：58 / 62

页数：5

共 17 条

[1] Rosuvastatin [J].

Carswell, CI ;

Plosker, GL ;

Jarvis, B .

DRUGS, 2002, 62 (14) :2075-2085

[2] Nonalcoholic fatty liver disease [J].

Clark, JM ;

Brancati, FL ;

Diehl, AM .

GASTROENTEROLOGY, 2002, 122 (06) :1649-1657

[3]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[4] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[5] Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care - The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT) [J].

Furberg, CD ;

Wright, JT ;

Davis, BR ;

Cutler, JA ;

Alderman, M ;

Black, H ;

Cushman, W ;

Grimm, R ;

Haywood, LJ ;

Leenen, F ;

Oparil, S ;

Probstfield, J ;

Whelton, P ;

Nwachuku, C ;

Gordon, D ;

Proschan, M ;

Einhorn, P ;

Ford, CE ;

Piller, LB ;

Dunn, JK ;

Goff, D ;

Pressel, S ;

Bettencourt, J ;

deLeon, B ;

Simpson, LM ;

Blanton, J ;

Geraci, T ;

Walsh, SM ;

Nelson, C ;

Rahman, M ;

Juratovac, A ;

Pospisil, R ;

Carroll, L ;

Sullivan, S ;

Russo, J ;

Barone, G ;

Christian, R ;

Feldman, S ;

Lucente, T ;

Calhoun, D ;

Jenkins, K ;

McDowell, P ;

Johnson, J ;

Kingry, C ;

Alzate, J ;

Margolis, KL ;

Holland-Klemme, LA ;

Jaeger, B ;

Williamson, J ;

Louis, G .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (23) :2998-3007

[6] Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia [J].

Hunninghake, D ;

Insull, W ;

Knopp, R ;

Davidson, M ;

Lohrbauer, L ;

Jones, P ;

Kafonek, S .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) :635-639

[7] Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial) [J].

Jones, PH ;

Davidson, MH ;

Stein, EA ;

Bays, HE ;

McKenney, JM ;

Miller, E ;

Cain, VA ;

Blasetto, JW ;

STELLAR Study Grp .

AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (02) :152-160

[8]

*MED EC COMP, 2000, PHYS DESK REF

[9] Liver fibrosis attributed to lipid lowering medications: two cases [J].

Punthakee, Z ;

Scully, LJ ;

Guindi, MM ;

Ooi, TC .

JOURNAL OF INTERNAL MEDICINE, 2001, 250 (03) :249-254

[10] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

← 1 2 →